Menopausal hormone therapy for the management of osteoporosis

A Gosset, JM Pouillès, F Trémollieres - Best Practice & Research Clinical …, 2021 - Elsevier
Postmenopausal osteoporosis is a frequent clinical condition which affects nearly 1 in 3
women. Estrogen deficiency leads to rapid bone loss which is maximal within the first 2–3 …

Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status

MF Munsell, BL Sprague, DA Berry… - Epidemiologic …, 2014 - academic.oup.com
To assess the joint relationships among body mass index, menopausal status, and breast
cancer according to breast cancer subtype and estrogen-progestin medication use, we …

2016 IMS Recommendations on women's midlife health and menopause hormone therapy

RJ Baber, N Panay, A Fenton - Climacteric, 2016 - Taylor & Francis
Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

Treatment of symptoms of the menopause: an endocrine society clinical practice guideline

CA Stuenkel, SR Davis, A Gompel… - The Journal of …, 2015 - academic.oup.com
Objective: The objective of this document is to generate a practice guideline for the
management and treatment of symptoms of the menopause. Participants: The Treatment of …

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health

TJ De Villiers, A Pines, N Panay, M Gambacciani… - …, 2013 - Taylor & Francis
Ten years after the first results from the Women's Health Initiative (WHI) trial were published,
it seems that the atmosphere around the issue of menopausal hormone therapy (MHT) is …

The 2017 hormone therapy position statement of The North American Menopause Society.

PF Schnatz - Menopause (New York, NY), 2017 - scholarcommons.towerhealth.org
Abstract The 2017 Hormone Therapy Position Statement of The North American Menopause
Society (NAMS) updates the 2012 Hormone Therapy Position Statement of The North …

Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice

AR Genazzani, P Monteleone… - Human reproduction …, 2021 - academic.oup.com
BACKGROUND Menopausal symptoms can be very distressing and considerably affect a
woman's personal and social life. It is becoming more and more evident that leaving …

Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases

Y Vinogradova, C Coupland, J Hippisley-Cox - Bmj, 2020 - bmj.com
Objective To assess the risks of breast cancer associated with different types and durations
of hormone replacement therapy (HRT). Design Two nested case-control studies. Setting UK …

Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures

O Golubnitschaja, M Debald, K Yeghiazaryan, W Kuhn… - Tumor Biology, 2016 - Springer
Rapidly increasing incidence of breast cancer is a new social challenge resulting from a
spectrum of internal and external risk factors which appear to be well accepted as an …

Pregnancy and breast cancer: pathways to understand risk and prevention

PF Slepicka, SL Cyrill, CO Dos Santos - Trends in molecular medicine, 2019 - cell.com
Several studies have made strong efforts to understand how age and parity modulate the
risk of breast cancer. A holistic understanding of the dynamic regulation of the …